Molecular Diagnostics For Sexually Transmitted Diseases Market Growth Outlook: Why Analysts Expect Continued Expansion
Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Molecular Diagnostics For Sexually Transmitted Diseases Market CAGR Outlook And Future Development
The market size for molecular diagnostics related to sexually transmitted diseases has experienced rapid growth in recent years. It is projected to expand from $3.67 billion in 2025 to $4.07 billion in 2026, at a compound annual growth rate (CAGR) of 10.7%. This growth observed in the historical period can be attributed to factors such as the reliance on conventional serological tests, the limited availability of automated PCR systems, a lack of awareness regarding molecular diagnostics in emerging markets, the increasing prevalence of sexually transmitted infections, and manual, labor-intensive testing workflows.
The molecular diagnostics for sexually transmitted diseases market is projected to experience substantial expansion in the coming years. This market is set to reach $6.05 billion in 2030, showing a compound annual growth rate (CAGR) of 10.4%. This anticipated growth is linked to factors such as technological progress in automated PCR and nucleic acid extraction, the broadening availability of point-of-care molecular diagnostics, improvements in healthcare infrastructure within developing areas, the increasing implementation of laboratory information management systems (LIMS), and greater investment in research and development for quick and comprehensive diagnostic assays. Key trends during this period encompass the growing acceptance of nucleic acid-based testing approaches, the proliferation of point-of-care molecular diagnostic solutions, an escalating need for swift and precise STD detection, the merging of molecular diagnostics with laboratory information systems, and the development of automated PCR and high-throughput diagnostic platforms.
Get A Free Sample Report With In-Depth Market Insights:
Molecular Diagnostics For Sexually Transmitted Diseases Market Growth Drivers: What’s Behind The Acceleration?
The increasing incidence of sexually transmitted infections is anticipated to drive forward the expansion of the molecular diagnostics for sexually transmitted diseases market. Sexually transmitted infections (STIs) are defined as ailments resulting from bacteria, viruses, or parasites spread via sexual interaction, impacting both the reproductive and urinary systems. The rise in STIs is predominantly attributed to the inconsistent application of protective measures. Such insufficient protection contributes to the simpler spread of these infections among sexually active populations. Molecular diagnostic methods for sexually transmitted infections (STIs) are crucial for managing these conditions, as they allow for the precise and early identification of pathogens, even in those without symptoms, thereby enabling prompt treatment, decreasing disease spread, and enhancing overall results for patients. As an illustration, data from June 2024 released by the UK Health Security Agency (UKHSA), a UK-based government agency, showed that England recorded 401,800 new STI diagnoses in 2023, representing a 4.7% rise from the 383,789 cases documented in 2022. Consequently, the escalating prevalence of sexually transmitted infections is fueling the expansion of the molecular diagnostics for sexually transmitted diseases market.
Molecular Diagnostics For Sexually Transmitted Diseases Market Segmentation And Category Overview
The molecular diagnostics for sexually transmitted diseases market covered in this report is segmented –
1) By Product: Instruments And Services, Consumables, Software
2) By Technology: Laboratory Testing, Point-Of-Care Testing
3) By Application: Chlamydia Trachomatis (CT) Or Neisseria Gonorrhoeae (NG) Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus (HSV) Testing, Human Papillomavirus (HPV) Testing, Human Immunodeficiency Virus (HIV) Testing, Trichomonas, Ureaplasma And Mycoplasma, Other Applications
Subsegments:
1) By Instruments And Services: Molecular Diagnostic Analyzers, Automated Polymerase Chain Reaction Systems, Nucleic Acid Extraction Instruments, Diagnostic Service Providers, Maintenance And Calibration Services, Installation And Training Services
2) By Consumables: Deoxyribonucleic Acid Extraction Kits, Ribonucleic Acid Extraction Kits, Polymerase Chain Reaction Reagents, Nucleic Acid Probes, Control And Reference Standards, Detection Enzymes And Buffers
3) By Software: Data Interpretation And Reporting Software, Polymerase Chain Reaction Workflow Management Software, Laboratory Information Management Systems, Diagnostic Decision Support Software, Quality Control Monitoring Software
Molecular Diagnostics For Sexually Transmitted Diseases Market Trends: What’s Defining The Industry’s Next Phase?
Leading companies in the molecular diagnostics for sexually transmitted diseases market are concentrating on developing innovative solutions, such as rapid point-of-care polymerase chain reaction (PCR) devices, to enhance diagnostic speed, accuracy, and accessibility. These rapid point-of-care PCR devices are portable molecular diagnostic tools that integrate sample preparation, amplification, and detection into a single, compact unit, enabling timely and highly sensitive pathogen detection outside traditional laboratory settings. For instance, in March 2025, Visby Medical, a US-based diagnostic technology company, introduced the Visby Medical Women’s Sexual Health Test. This product is a single-use, handheld PCR device designed to identify chlamydia, gonorrhea, and trichomoniasis from vaginal samples within 30 minutes. It operates without requiring external instrumentation or cold-chain logistics, features an integrated amplification system, and provides lab-quality results directly at the point of care to support immediate clinical decisions. The test is authorized for prescription home use, making it the first U.S. Food and Drug Administration (FDA)-cleared molecular diagnostic test for multiple sexually transmitted infections (STIs) that can be utilized beyond clinical settings. This launch signifies a shift toward decentralized diagnostic solutions that broaden accessibility, especially for underserved or remote populations.
Molecular Diagnostics For Sexually Transmitted Diseases Market Key Participants And Competitive Landscape
Major companies operating in the molecular diagnostics for sexually transmitted diseases market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Illumina Inc., Hologic Inc., bioMérieux S.A., QuidelOrtho Corporation, QIAGEN N.V., Cepheid, Sansure Biotech Inc., OraSure Technologies Inc., Meridian Bioscience, Seegene Inc., Visby Medical Inc., Zeesan Biotech, Binx Health Inc., GCC Biotech, GeneProof, Solone Life Sciences India (P) Ltd.
View The Full Molecular Diagnostics For Sexually Transmitted Diseases Market Report:
Molecular Diagnostics For Sexually Transmitted Diseases Market Geographic Analysis: Where Is Demand Rising Fastest?
North America was the largest region in the molecular diagnostics for sexually transmitted diseases market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the molecular diagnostics for sexually transmitted diseases market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
